Public Health Expenditures, Income and Health Outcomes in the Philippines by Deluna, Roperto Jr & Peralta, Tiffany Faith
MPRA
Munich Personal RePEc Archive
Public Health Expenditures, Income and
Health Outcomes in the Philippines
Roperto Jr Deluna and Tiffany Faith Peralta
University of Southeastern Philippines, School of Applied Economics
April 2014
Online at http://mpra.ub.uni-muenchen.de/60115/
MPRA Paper No. 60115, posted 24. November 2014 10:51 UTC
PUBLIC HEALTH EXPENDITURES, INCOME AND HEALTH OUTCOMES  
IN THE PHILIPPINES 
 
Tiffany Faye S. Peralta and Roperto S. Deluna, Jr. 
 
Abstract  
 
This paper studied the relationship among public health expenditures, income and health 
outcomes in the Philippines. Infant mortality rate, under five mortality rate and life 
expectancy were used as proxy for health outcomes. Specifically, this paper presented the 
profile of government health expenditures, income and health outcomes from 1981 to 
2010. The study used Vector Autoregressive Analysis and Granger Causality test to 
determine the direction of relationship of the variables. 
  
Results revealed that health expenditure per capita followed an overall increasing trend 
with an average growth rate of 6.49% and GDP per capita with an average growth rate of 
11% from 1981 to 2010. These correspond to the reduction of infant mortality rate by 
1.64% on average, under five mortality by 1.76% and the increase in life expectancy with 
an average growth of 0.17% from 1981 to 2010. However, VAR results revealed that the 
past values of public health expenditure has no effect on under-five mortality rates but 
affects infant mortality rate. This may suggest that the past and present level of health 
expenditure is not sufficient enough to affect under five mortality rate but is effective 
enough on alleviating infant mortality rate. Conversely, past and present values of GDP per 
capita is not sufficient enough to affect infant mortality rate but affects under five mortality 
rate in the Philippines. VAR estimation also revealed that both health expenditure and GDP 
per capita has a positive and significant effect on life expectancy. Thus, to improve life 
expectancy and to reduce child mortality rates in line with the Millennium Development 
Goals, it requires effective and sufficient health expenditure and a sustainable economic 
growth. 
 
Introduction 
 
It is well-recognized that the government is taking responsibility for the quality of the 
water that people drink, the level of immunization of a population and campaigns to  
stop the spread of HIV/AIDS or to encourage physical exercise. Government-funded public 
health activity plays an important part in a country’s health development, through 
strengthening health systems and generation of human, financial and other resources. This 
allows health systems to achieve their goals of improving health, reducing health 
inequalities, securing equity in health care financing and responding to population needs.  
 
Health expenditure consists of all expenditures or outlays for medical care, prevention, 
promotion, rehabilitation, community health activities, health administration and 
regulation and capital formation with the predominant objective of improving health 
(OECD, 2011). Much of the social budget work is focused on ensuring more effectively 
channeled public sector resources for the social sectors, with the ultimate objective of 
improving the welfare of children, women and other marginalized groups in the society. 
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Public expenditure for health care is important for improving health outcomes especially 
for the poor as the poor are more likely to obtain health care from publicly provided 
facilities. 
 
Health is indeed closely intertwined with economic growth and sustainable development. 
There is evidence that investing in health brings substantial benefits for the economy. 
According to the WHO (2001) increasing life expectancy at birth by 10% will increase the 
economic growth rate by 0.35% a year. Health and economic matters are intimately linked 
in a number of ways. First, health is an important contributor to people’s ability to be 
productive and to accumulate the knowledge and skills they need to be productive. Second, 
health status is also a major determinant of one’s enrollment in and success in school, 
which itself is an important contributor to future earnings. Third, the costs of health care 
are also extremely important to individuals, especially to poor people, because large out of 
pocket expenditures can have a major impact on their financial status and can push them to 
poverty. Fourth, the costs of health care are also very important to countries, because 
health is a major item of national expenditure of all countries. Finally, the approach that 
different countries take to the financing and carrying out of health services raises 
important issues of equity (Jones and Bartlett, 2006).   
 
WHO defines health as a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity. It moves beyond a focus on individual behavior 
towards a wide range of social and environmental interventions.  Another major initiative 
for improved global health is the United Nations Millennium Declaration. It was agreed to 
in 2000 by 189 countries including Philippines, exemplifying an unprecedented 
commitment on the part of both rich and poor countries to attain improvements in human 
development by the year 2015. This commitment is summarized in the eight Millennium 
Development Goals (MDGs) that set targets in areas of poverty reduction, health 
improvements, education attainment, gender equality, environmental sustainability, and 
fostering global partnerships (UNDP 2003). These movements are formed for the 
betterment of health outcomes. 
 
Income has a strong effect on health. It imparts more than 75% of total expenditures for 
health. Past studies show that the poor are significantly less healthy than the rich and that 
the rich are more likely to obtain medical care. Hence, it is the level of health care financing 
that can bridge the gap between the health status of the poor and the rich. This indicates 
that income, as such, is of great importance for the risk of illness (Gwatkin, 2000).  
 
Philippine Context 
 
Health outcomes represent how healthy a country is and assesses the quality of health care 
in the country.  Its importance is completely acknowledged in existing exogenous and 
endogenous growth theories, yet what still arguable is what factors should be considered 
as health outcomes. In most studies, early childhood development is the core for the 
succession of health care. Infant mortality, under-five mortality are used as indicators for 
health outcomes under early childhood development.  
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Life expectancy is also employed as proxy for health outcomes, the intuition is that the 
longer an average person lives, or the more he spends on health care, the better his health 
must be. Health outcome is a change in the health of an individual, group of people or 
population which is attributable to an intervention or series of interventions (Berkman, et 
al, 2011). 
 
In 2010, the government’s main goal in its new health sector plan was to achieve universal 
health care under Republic Act No. 7875. The plan was to increase the number of poor 
people enrolled in PhilHealth, a government mandatory health insurance program that 
seeks to provide universal health insurance coverage and ensure affordable, acceptable, 
available, accessible, and quality health care services for all Filipinos, and to improve the 
outpatient and inpatient benefits package. A full government subsidy is offered to the 
poorest 20% of the population, and premiums for the second poorest 20% will be paid in 
partnership with the Local Government Units. This measure has led to an explosion of 
members and beneficiaries of this component.  
 
Figure 1 shows the public health expenditures among the ten selected Asian countries. 
Health expenditure of a country should be at least 5% of its Gross Domestic Product (GDP). 
Based on the 2013 statistics of the WHO, the total health expenditure ratio of the 
Philippines improved from 3.2% in 2000 to 4.1% in 2010, albeit still below the bench mark. 
Philippines ranked 5th both in 2000 and 2010. Health spending in the country grew by 
P38.8 Billion or 13.9% annually (www.senate.gov.ph).  
 
 
 
Figure 1. Health expenditure as % of GDP, 2000 and 2010. 
      Source: WHO World Health Statistics 2013 
 
  
In achieving MDG 4 by 2015, reducing child mortality rates, the country set effective and 
well-defined child health and related programs carried out by the Department of Health, in 
collaboration with the local government units. The programs offer a range of interventions 
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that are appropriate at various life cycle stages, from maternal care to care of the newborn 
up to integrated management of child health. 
 
The economy of the Philippines is one of the emerging markets in the world. However, 
major problems remain, mainly having to do with alleviating the wide income and growth 
disparities between the country's different regions and socioeconomic classes and other 
necessities to ensure future growth. 
 
Figure 2 shows the GDP per capita growth among the ten selected Asian countries, showing 
the improvement from 2000 to 2010. Income, expressed as GDP per capita has been 
significantly improving. The Philippines’ per capita income in 2011 finally stood at about 
more than $2,000. Still, it ranked lower among Southeast Asian countries specifically 
Indonesia with the average of $3,000, $4,700 for Thailand, and $8,400 for Malaysia (IMF, 
2013). 
  
Figure 2: GDP per capita growth (annual %), 2000 and 2010 
      Source: World Bank National Accounts Data 
 
Along with these improved GDP per capita and expenditures for health of the country are 
observed health outcomes. Over the years, the overall health condition of Filipinos has 
shown improvement as indicated by declining mortality rates and longer life span. Recent 
data shows that life expectancy at birth increased by four years over the period 1997-2006, 
from 67 years in 1997 to 71 years in 2006. Infant and under-five mortality rates have also 
improved over the years. From 29 infant deaths per 1,000 live births in 2003, the IMR in 
2008 improved to 24 deaths per 1,000 live births in 2008. Under-five mortality rate also 
declined from 40 deaths per 1,000 live births in 2003 to 34 deaths in 2008 (Cabral, 2010).  
 
Objectives of the Study 
 
 The general objective of the study is to test the relationship of health expenditures, income 
and health outcomes in the Philippines. Specifically, the study aims: 
1. to present the trend for health expenditures, per capita income and health outcomes 
of the Philippines from 1981 to 2010; and 
2. to provide empirical evidence on the relationship of health expenditures, GDP per 
capita and health outcomes in the Philippines. 
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Conceptual Framework 
 
Several conclusions can be drawn from literatures on the relationship among income, 
health expenditure and health outcomes. GDP per capita is often considered an indicator of 
a country's standard of living or income (Gutierez et al, 2007). Income of households is the 
main source on expenditures for health. Health expenditure is invested to improve health 
outcomes. To the extent that health expenditure increases health outcomes, it will also 
affect income if healthier populations also produce higher levels of income. As a concept of 
human capital, health outcomes can also bring improvement to income and can also change 
the government spending for health. Figure 3 shows the possible flow of relationship 
between income and health expenditure to health outcomes. Hypothetically, income and 
health expenditure affects the health outcomes of the country. This effect may either be 
negative or positive. If positive, this implies that if income and health expenditure 
increases, it will lead to an improvement on health outcomes of the Philippines. On the 
other hand if income and health expenditure are found to be insignificant then it implies 
that income and health expenditure has nothing to do with health outcomes.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Mechanisms relating income and health expenditures on health                       
outcomes. 
 
Data 
 
The study used annual data of income, health expenditures and health outcomes from 1980 
to 2010, a total of 30 observations. Data on health expenditures were obtained from 
General Appropriations Act (GAA), publication of Department of Budget and Management 
(DBM). Data on health outcomes and income were obtained from World Bank website.  
 
 
Statistical Method 
 
The statistical model being done was composed of two phases. Phase I is the analysis of 
trends of GDP per capita, health expenditure and the 3 health outcomes. Phase II is 
composed of time series analysis in order to determine the relationships of the 
aforementioned variables. 
PUBLIC HEALTH 
EXPENDITURE  
HEALTH OUTCOMES 
Infant Mortality 
Under- five Mortality 
Life Expectancy 
 
 
  
INCOME 
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Phase I. Trends of Income, Health Expenditure 
    and Health Outcomes 
 
The trends of income, health expenditure and health outcomes of the Philippines during 
the period 1981 to 2011 is presented and examined through graphs and tables. The 
process used Microsoft Excel 2007. 
 
Phase II. Relationship of Income, Health Expenditure  
     and Health Outcomes 
 
Time series analysis was used to identify the relationship of income, health expenditure 
and health outcomes. A time series is a collection of observations of well-defined data items 
obtained through repeated measurements over time.  
 
A. Testing for Stationarity 
 
Most time series analysis need to check for unit roots in each series before estimating any 
equation. According to Granger and Newbold (1974), if there is a unit root then that 
particular series is considered as non-stationary. The result is stationary if the stochastic 
properties of the series remain unchanged over time. ). A stochastic time series {Yt} is said 
to be stationary, if and only if, it satisfies the following assumptions:  
(1) E[Yt]= µ 
(2) Var (Yt)= σ2 
(3) Cov (Yt,Yt-k)=σk 
 
Conditions (1) and (2) imply that Yt has a constant means and variance overtime, while 
condition (3) means that the covariance between observations depends only on how far 
apart they are, and not on the time of occurrence (Danao, 2002). If one or more of the 
above conditions would not be satisfied, it means that the series is non-stationary, and 
proceeding with regression analysis would result to spurious results, which can produce 
high R2 and t-statistics, but without any coherent economic meaning or has insignificant 
result. 
  
B. Testing for Unit Roots 
 
Many time series data exhibit trending behavior or nonstationary. If the data are trending, 
then some form of trend removal is required (Danao, 2002).  
 
To determine whether the data is stationary or not, it is necessary to conduct a standard 
unit root test. The Augmented Dicky-Fuller (ADF) was used in testing for the presence of 
unit root and this was applied to the natural logs of the data series (economics.about.com). 
The time series data in this study could take any of the stationarity models as: 
 
 ∆ Yt = ץY t-1 + εt                         (random walk)    (1) 
 ∆ Yt = σ 0 + ץ Y t-1 + εt                  (random walk with a drift)  (2) 
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 ∆Y t = σ 0 + σ 2 + ץY t-1 + εt           (mixed process)   (3) 
 
The error term is assumed to be independent and identically distributed. Dickey and Fuller 
(1981) proposed the ADF test in order to handle the autoregressive process in the 
variables (Dickey and Fuller, 1979). If the ADF will indicate the occurrence of a unit root, 
then the series is non-stationary. In case of non-stationary, then we proceed to differencing 
until we arrive at a stationary series. 
  
Aside from Dickey-Fuller test, Phillips-Perron test is also used for unit root test. Phillips-
Perron test makes a non-parametric correction to the t-test statistic. The test is robust with 
respect to unspecified autocorrelation and heteroscedasticity in the disturbance process of 
the test equation.  
 
C. Differencing 
  
Differencing is frequently employed to detrend the data and control autocorrelation by 
subtracting each datum in a series from its predecessor (www.stat.ucla.edu). In case 
stationarity is attained after differencing d times then the series is said to be integrated of 
order d (Danao, 2002). In such case, one can then proceed with cointegration analysis. In 
this study, the data series were found to be stationary so that the next appropriate analysis 
is VAR. 
 
D. Lag Order Determination 
  
In order to have an appropriate set of variables to be included in the VAR model, it is 
necessary to determine the appropriate lag order (Danao, 2002). The popular methods 
used for lag order determination are the Akaike Information Criterion (AIC), and Schwarz-
Bayesian Criterion (SBC). The main idea of AIC is to select the model that minimizes the 
negative likelihood penalized by the number of parameters. On other hand, Schwarz 
Bayesian Criterion (Cavanaugh and Neath, 1999) is one of the widely used information 
criteria. SBC is derived within a Bayesian framework as an estimate to the Bayes factor for 
two competing models. 
  
Both AIC and SBC differ in their exact definition of a good model. In this case, we will 
choose the model which has the lowest AIC and SBC value. The AIC and SBC equations are 
given below: 
AIC = Tlog |∑ | + 2N      (4) 
SBC = Tlog |∑ | + Nlog (T)     (5) 
Where: 
|∑ | = the determinants of the variance /covariance matrix of the residuals; 
N   = total number of parameters estimated in all equation; and 
T = the number of usable observations. 
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E. Vector Autoregressive (VAR) Model 
  
According to Sims (1980) and Litterman (1976, 1986) Vector Autoregressive (VAR) models 
have been proven to forecast better than any simultaneous equation models. Vector 
Autoregressive (VAR) models provides information about a variable’s forecasting ability 
for the other variable. It is an econometric model used to capture the evolution and the 
interdependence between multiple time series. A VAR model describes the evolution of a 
set of k variables over the same sample period (t=1..., T) as a linear function of only their 
past evolution. The variables are collected in a K x 1 vector Yt (or Xt), which has the element 
Yt (or Xt), the time t observation of variable Y (or X). A (reduced) p-th order VAR denoted 
VAR (p) where the K-periods back observation Yt-k (or Xt-k) is called the K-th lag of Y (or X). 
For example, if the Y variable is GDPpc, then Yt is the value of GDPpc at time t 
(http://en.wikipedia.org).  
  
In its simplest term, a VAR is an unrestricted form model that expresses each other variable 
in the system. Using the three variables considered in the study, VAR model specification of 
a multivariate VAR model is illustrated as: 
 
E.1. Infant Mortality Rate  
 
HExpt 
  
C1 
 
A1,1(1) A1,2(1) A1,3(1) 
 
HExpt-1 
  
A1,1(k) A1,2(k) A1,3(k) 
  
Hexpt-k 
  
ε1t 
               
GDPpct = C2 A2,1(1) A2,2(1) A2,3(1) GDPpct-1   +….     A2,1(k) A2,2(k) A2,3(k)   + GDPpct-k   + ε2t   
           
IMRt  C3 A3,1(1) A3,2(1) A3,3(1) IMRt-1  A3,1(k) A3,2(k) A3,3(k)  IMRt-k  ε3t 
 
E.2. Under five mortality rate  
 
HExpt 
  
C1 
 
A1,1(1) A1,2(1) A1,3(1) 
 
HExpt-1 
  
A1,1(k) A1,2(k) A1,3(k) 
  
Hexpt-k 
  
ε1t 
               
GDPpct = C2 A2,1(1) A2,2(1) A2,3(1) GDPpct-1   +….     A2,1(k) A2,2(k) A2,3(k)   + GDPpct-k   + ε2t 
           
U5MRt  C3 A3,1(1) A3,2(1) A3,3(1) U5MRt-1  A3,1(k) A3,2(k) A3,3(k)  U5MRt-k  ε3t 
 
E.3. Life Expectancy  
HExpt  C1 A1,1(1) A1,2(1) A1,3(1) HExpt-1  A1,1(k) A1,2(k) A1,3(k)  Hexpt-k  ε1t 
               
GDPpct = C2 A2,1(1) A2,2(1) A2,3(1) GDPpct-1   +….     A2,1(k) A2,2(k) A2,3(k)   + GDPpct-k   + ε2t 
           
LEt  C3 A3,1(1) A3,2(1) A3,3(1) LEt-1  A3,1(k) A3,2(k) A3,3(k)  LEt-k  ε3t 
 
 
where: 
   t              = time subscript; 
  Hexppct   = health expenditure per capita observed at time t; 
  GDPpct    = GDP per capita observed over at time t; 
  IMR       = infant mortality rate observed at time t; 
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  U5MR      = under five mortality rate observed at time t; 
  LE       = life expectancy observed at time t; 
   aij                = coefficients of the matrices associated to the VAR, the subscripts           
  denote the order of the matrix; 
   c1, c2  and c3 = constants; and 
   ɛt                           = the error terms 
 
The significant characteristics that the error term must hold in a standard VAR model are 
as follows: 
 
1. E (ɛt) = 0, where every error term has mean zero; 
2. E (ɛt, ɛ’t-k) = Ω, the contemporaneous covariance matrix of error terms is Ω (a 
n × npositive definite matrix); 
3. E =(ɛt,ɛ’t-k) = 0, for any non-zero k - there is no correlation across time; in 
particular, no serial correlation in individual error terms 
 
F. Granger Causality Test 
 
Granger causality takes into account prediction rather than causation as it name would 
suggest. This is because, in Granger sense, causality is a concept regarding statistical 
preference and does not necessarily refer to a causal relationship in the economic sense. 
The approach is based on the idea that the past can cause the future, but the future cannot 
cause the past. It is more on “X causes Y”, if the past values of X can be used to predict Y, 
better than the past values itself (www.eviews.com). Granger causality can be tested by 
using a standard F-test on the lagged values of X, together with lagged values of Y. If results 
will generate statistically significant values of X to the explanation of the future values of Y, 
this would mean that X Granger causes Y. 
 
Estimation Procedure 
 
The Shazam version 11 was used to test the presence of unit root in the series of variables. 
To estimate the VAR model and to execute the Granger Causality analysis, the Eviews 
package version 5 was used. 
 
Results and Discussion 
 
This section shows the time series plots for the health expenditure per capita, GDP per 
capita and the three health outcomes: infant mortality rate, under five mortality rate and 
life expectancy  of the Philippines from 1981-2010. The trends of the variables for 30 years 
are all plotted in Figures 3 and 4. 
Health expenditure has an overall increasing trend with a growth rate  of 6.49% from 1981 
to 2010. Figure 3 shows an increasing trend of health expenditure per capita from 1981 to 
1990 but shows a sudden decrease in 1991. An increase in health expenditure in 1992 was 
attributed to the increase in LGU spending resulted from the enactment of decentralization 
under the Local Government Code of 1991 that  devolved the health  services from the 
national to the local governments. This law mandates the provincial governments to 
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manage secondary level facilities, such as the district hospitals, while the municipalities 
take charge of the primary level facilities. In 1997, PhilHealth assumed the responsibility of 
administering the Medicare Programme for government employees from the Government 
Service Insurance System (GSIS) and in 1998, for private sector employees from the Social 
Security System (SSS).  
 
 
 
 
 
 
 
 
 
 
Figure 3. GDP per capita, Health Expenditure, Infant and Under Five Mortality of        
the Philippines, 1981 to 2010. 
 
 
 
 
 
 
 
 
 
There was also an observed increase in health expenditure on 2008 due to the increase in 
government spending to finance 94% DOH hospitals and also  to  finance other  DOH 
projects such as Universally Accessible Cheaper and Quality Medicines, Health Sector 
Development Program, Rural Water Supply and Sanitation Project Phase V, and LGU Urban 
Water and Sanitation Project. The government had incurred additional loans to fund the 
said projects. It is also observed that there was a large increase of health expenditure in 
2009 which accounts 40% increment from the previous year . According to the WHO, the 
ideal health expenditure of developing countries must be 5% of the GDP of the country. 
However, Philippines’ health expenditure has only about 4.1% of GDP as of 2010 
(en.wikipedia.org).   
  
The GDP per capita series used as proxy for income in this study that is presented in Figure 
3. It follows a smooth increasing trend from 1981 to 2010 with an average growth rate of 
11%, an indication of nonstationary process. Despite of the increasing trend, it is noticeable 
that GDP per capita decreased from 1984 to 1985 which accounts a -7.31% growth rate. 
During these years, economic misconduct and political instability during the Marcos regime 
contributed to economic stagnation and resulted in macroeconomic instability. There was a 
severe recession from 1984 through 1985. The real GDP of the country continued to 
increase in the subsequent years. In 2008, Philippines was in its difficult year the growth 
slowed significantly and poverty increased, driven in part by rising fuel and food prices. 
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However the real gross domestic product recovered from stagnation and achieved a better 
performance in proceeding years. Furthermore, the real Gross Domestic Product (GDP) has 
been on an upward trend until 2010. 
  
These increasing level of health expenditure and GDP per capita are accompanied by a 
reduction of infant mortality rate by 1.64% and under five mortality rate by 1.76% from 
1981 to 2010. This reduction means an improvement on the status of mortality rates. 
Figure 3 shows an overall decreasing trend especially from 1981 to 2006. Infant mortality 
rate is continuously decreasing from 51.4% in 1981 to 21% in 2010. Under five mortality 
rate shows a more decreasing trend compared to infant mortality rate, which declines from 
76.9% in 1981 to 26.4% in 2010. The target of MDG for 2015 is to reduce infant mortality 
rate to 19% and 26.7% for under five mortality rate. The figure shows that the country has 
high possibility on achieving these goals. 
  
Life expectancy, another indicator for health outcomes have shown continuous increasing 
trend from 1981 to 2010 with an average of 0.167 as shown in figure 4. Life expectancy has 
improved from 63.7 in 1981 to 68.5 in 2010.  
  
Figure 4. GDP per capita, Health Expenditure and Life Expectancy in the  Philippines, 1981 
to 2010. 
 
Generally, Figures 3 and 4 shows improvement of health outcomes along with increasing 
levels of GDP per capita and health expenditures. To empirically examine the relationship 
among these variables, Vector Autoregressive Analysis was employed. 
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Relationship among Income, Health Expenditure and Health Outcomes 
 
Stationarity Tests 
  
In dealing with time series analysis, the stationarity properties of the series are important. 
This was initially tested using correlograms derived from Autocorrelation Function (ACFs) 
and Partial Autoccorelation Functions (PACFs).  
  
The correlograms of the ACF and PACF of Hexp, GDPpc, IMR, U5MR, and LE are presented 
in Appendices 1 to 3 respectively. The results show that the correlograms of the 
aforementioned variables are decaying rapidly which is an indication of a stationary series. 
However, due to the possibility of subjective conclusions that can be derived from 
evaluating stationarity through graphs, Augment Dickey-Fuller tests were performed to 
check formally if the series are statistically stationary. Results of the unit root tests are 
summarized in Table 2.  
 
Table 2. Augmented Dickey Fuller (ADF) test results. 
Variable Random Walk Random Walk w/ 
Drift 
Mixed Process 
Hexppc 
GDPpc 
IMR 
U5MR 
LE 
1.4075ns 
15.173* 
-3.9478*  
-3.7944* 
-27.587*      
0.21938ns 
8.4320* 
-4.2125*   
-3.7131*  
-7.1449*             
1.5122ns 
36.843* 
9.0176* 
6.7228* 
39.592*                      
ns not significant at 10% level   *   Significant at 10% level  
 
The test results for presence of unit roots for the aforementioned variables revealed that 
the series are stationary confirming earlier results from the correlogram except for health 
expenditure per capita. The values are tested at 10% significant level.  
 
Differencing of Health Expenditure per capita 
  
The result of the ADF test revealed that series of Hexppc exhibits unit root. This would 
mean that Hexppc is nonstationary. The main premise for differencing health expenditure 
per capita is to remove the underlying trend effect.  Using the first difference value 
(Appendix 5), the variable was found to be stationary at first differencing. This implies that 
the variable attained stationarity after first differencing and the series is said to be 
integrated of order 1. 
 
Table 3 presents the result of the ADF test for the variable Hexppc after first differencing.  
 
Table 3: Augmented Dickey Fuller (ADF) test results for Hexppc in first differenced. 
Variable   Random Walk   Random Walk with Drift    Mixed Process 
 Hexppc    -3.9666*        -4.2421*                     -4.3157*     
* Significant at 10% level  ns Not significant 
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This is significant under the three processes. 
 
Lag Order Determination 
 
Cointegration is not possible in this study since the variables are not integrated of the same 
order, the next alternative estimation would be the Vector Autoregressive (VAR) modeling. 
Specification of correct lag order in VAR modeling is one of the important components to 
be considered in time series analysis. The selection of inappropriate p will decrease the 
accuracy of the estimated coefficients in VAR (p) model. In determining the lag, the lowest 
value of AIC and SBC was the chosen lag of the variables. In addition, the highest value of 
LR test statistic also helps in determining the lag order. VAR lag order selection were done 
using EViews package version 5.0. Table 4 shows the results of lag order selection of the 
three VAR models.  
 
Table 4: VAR Lag Order Selection Criteria. 
Lag LR AIC SC 
GDPPC, HEXPPC and IMR  
0 NA   22.88202  23.02829 
1  228.2589  12.43246*  13.31761* 
2  18.36162*   12.73255  13.45631 
3  7.532222  12.65031  14.11296 
4  3.679067  13.06372  14.96517 
GDPPC, HEXPPC and U5MR  
0 NA   24.37556  24.52183 
1   233.4030*  13.98113   14.56619* 
2  13.72600   13.93858*  14.96243 
3  6.894983  14.19891  15.66156 
4  11.22905  13.98316  15.88461 
    GDPPC, HEXPPC and LE 
0 NA   28.58641  28.73267 
1  229.1882*  14.08273*  5.54538* 
2  55.53430  16.02744  17.05130 
3   39.97069  18.39268    18.977741 
4  6.602388  14.25253  16.15398 
    
 * indicates lag order selected by the criterion 
 LR: sequential modified LR test statistic (each test at 5% level) 
 AIC: Akaike information criterion 
 SC: Schwarz information criterion 
 
In the three VAR models, LR, AIC and SBC show some conflicting results. In this case, SC 
was used to determine the appropriate lag length considering the study used annual data. 
As a result, VAR(1) was used to be the lag order of the three VAR models.  
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Vector Autoregression (VAR) Analysis 
 
A VAR is a simultaneous system of equations that examine the economic inter-relationship 
of variables which provides a statistical representation of the variables’ past interactions. 
Within this framework, all variables are treated symmetrically without any distinction of 
which variable is exogenous and endogenous. The variables were tested at 10% significant 
level. Table 5, 6 and 7 shows the VAR estimation results and the standard errors of the 
three VAR models. 
 
a. Infant Mortality Rate 
 
Table 5 shows the result of the VAR estimation outputs and the standard error of the VAR 
models consisting Hexppc, GDPpc, and IMR with a lag length of 1. Results revealed that 
infant mortality rate is reduced by an increased in the previous year’s health expenditure. 
That is, a thousand peso increase in health expenditure in the previous year will 
statistically reduce the current infant mortality rate by a very minimal 0.000025%.  
 
Table 5. Estimates for the Unrestricted VAR (1) Model for the Health Expenditure,        
GDP per capita and Infant Mortality Rate. 
 GDPPC HEXPPC IMR 
    
HEXPPC(-1)  0.079435ns  3.054915ns -0.000025* 
  (0.21170)  (2.71343)  (0.0000068) 
    
GDPPC(-1)  0.004588ns  0.886873* -0.000000101ns 
  (0.00620)  (0.07946)  (0.0000002) 
    
IMR(-1)  33.04187ns  3561.649*  1.024613* 
  (83.2308)  (1066.79)  (0.00268) 
    
C -57.39521ns  228.6579ns  0.003668* 
  (61.5164)  (788.470)  (0.00198) 
    
 Adj. R-squared 0.1119268  0.926638  0.999887 
 Log likelihood -132.0612 -203.4834  157.5102 
 Akaike AIC  9.718658  14.82024 -10.96502 
 Schwarz SC  9.908973  15.01055 -10.77470 
   
 Log likelihood -177.3056  
 Akaike information criterion  13.52183  
 Schwarz criterion  14.09277  
*Significant at 10% level   nsNot significant at 10% level 
 
Thus, health expenditure should further increase to substantially reduce infant mortality 
rate. Furthermore, level of current health expenditure is positively increased by previous 
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year’s values of GDP per capita and infant mortality rate. However, GDP per capita or 
improvement in income in the previous year has no effect on current level of infant 
mortality rate. This might suggest that GDP per capita is not sufficient to affect infant 
mortality rate. 
 
b. Under Five Mortality Rate 
 
Table 6 shows the result of the VAR estimation outputs and the standard error of the 
variables, HEXPpc, GDPpc, and U5MR with a lag length of 1. Results showed that health 
expenditure is not sufficient enough to affect under five mortality rate. However, results 
revealed that the value of GDP per capita a year ago improves the level of under-five 
mortality rate at the current year. Also, an improvement on last year’s level of under-five 
mortality rate will bring substantial progress to its level at present.  
 
Table 6. Estimates for the Unrestricted VAR (1) Model for the Health Expenditure,       
GDP per capita and Under Five Mortality Rate. 
 GDPPC HEXPPC U5MR 
 
HEXPPC(-1) 0.081771ns 3.331539ns -0.0000179ns 
 (0.21215) (2.76184) (0.000017) 
    
GDPPC(-1) 0.005515ns 0.939606ns -0.00000158* 
 (0.00562) (0.07319) (0.00000044) 
    
U5MR(-1) -8.711931ns -1727.060ns 0.980688* 
 (42.1492) (548.719) (0.00329) 
    
C -53.03020ns 1658.092ns -0.026718* 
 (78.6466) (1023.86) (0.00614) 
    
Adj. R-squared 0.224138 0.923954 0.999763 
Log likelihood -132.1279 -203.9863 132.6711 
Akaike AIC 9.723425 14.85617 -9.190795 
Schwarz SC 9.913740 15.04648 -9.000480 
   
Log likelihood -199.2623  
Akaike information criterion 15.09017  
Schwarz criterion 15.66111  
*Significant at 10% level   nsNot significant at 10% level 
 
c. Life Expectancy 
 
Table 7 shows the result of the VAR estimation outputs and the standard error of the 
variables, HEXPpc, GDPpc, and LE with a lag length of 1. Results presented in table 7 
16 
 
revealed that the value of health expenditure and GDP per capita a year ago has a positive 
effect to life expectancy. Thus, this implies that an increased health expenditure and GDP 
per capita a year ago would lead to an improvement in life expectancy at present. 
 
 Table 7. Estimates for the Unrestricted VAR (1) Model for the Health         
Expenditure, GDP per capita and Life Expectancy. 
 GDPPC HEXPPC LE 
 
HEXPPC(-1)  0.080689ns  3.140121  0.000498* 
  (0.21211)  (2.77861)  (0.00011) 
    
GDPPC(-1)  0.005394ns  0.933898*  0.0000106* 
  (0.00570)  (0.07470)  (0.000003) 
    
LE(-1)  1.139634ns  193.4058*  0.982426* 
  (4.78862)  (62.7304)  (0.00253) 
    
C -130.9375ns -11865.94*  1.197472* 
  (289.023)  (3786.17)  (0.15250) 
    
 Adj. R-squared 0.323546  0.923045  0.999870 
 F-statistic  0.792965  108.9512  69149.22 
 Log likelihood -132.1198 -204.1528  79.19857 
 Akaike AIC  9.722846  14.86806 -5.371326 
 Schwarz SC  9.913161  15.05837 -5.181011 
   
 Log likelihood -253.1702  
 Akaike information criterion  18.94073  
 Schwarz criterion  19.51167  
*Significant at 10% level   nsNot significant at 10% level 
 
 
Granger Causality Test 
 
The three VAR models test about the relationship among health expenditure per capita and 
GDP per capita of the three different health outcomes are limited to the current and lag 
values of the variables. The Granger Causality test will further determine if the historical 
values of one variable can forecast relationships among other variables. This test was done 
on the three models.  Table 8 presents the Granger causality test of variables. The null 
hypotheses were subjected to F-test at 10% significant level.  
 
Results of the Granger test revealed that health expenditure can forecast the future values 
of infant mortality rate and life expectancy. Results also revealed that GDP per capita can 
forecast the future values of the three health outcomes. As a concept of human capital, 
health is an important factor on achieving economic growth. Better health outcomes could 
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lead to improved income and an increase in real GDP per capita. Results revealed that the 
three health outcomes can forecast the future values of GDP per capita. 
 
 
Table 8. Results of the Granger Causality Test  
Null Hypothesis: F-Statistic Probability 
   
GDPPC does not Granger Cause HEXPPC 1.50276 0.23167ns 
HEXPPC does not Granger Cause GDPPC 1.03808 0.31803ns 
IMR does not Granger Cause HEXPPC 1.08160 0.30830ns 
HEXPPC does not Granger Cause IMR 13.5383 0.00112* 
IMR does not Granger Cause GDPPC 10.8024 0.00290* 
GDPPC does not Granger Cause IMR 5.17847 0.03135* 
U5MR does not Granger Cause HEXPPC 0.52621 0.47494ns 
HEXPPC does not Granger Cause U5MR 0.02977 0.86440ns 
U5MR does not Granger Cause GDPPC 9.44156 0.00493* 
GDPPC does not Granger Cause U5MR 12.3859 0.00161* 
   
LE does not Granger Cause HEXPPC 0.61060 0.44190ns 
HEXPPC does not Granger Cause LE 24.7918 0.000039* 
LE does not Granger Cause GDPPC 8.94487 0.00602* 
GDPPC does not Granger Cause LE 23.6805 0.000048* 
*Significant at 10% level   nsNot significant at 10% level 
 
 
Summary and Conclusion 
 
Results of trends analysis revealed that GDP per capita, with an average growth rate of 
11%, is continuously increasing through the period 1981 to 2010. Health expenditure, with 
an average growth rate of 6.49%, has shown fluctuating trend in early years but shows a 
distinctive increase in the later part. These correspond to the reduction of infant mortality 
rate by 1.64% on average, under five mortality rate by 1.76% and the increase in life 
expectancy with an average growth rate of 0.17% from 1981 to 2010. 
 
The results in VAR models verified the relationship at 10% level of significance of income, 
health expenditure and health outcomes. The results show that public health expenditures 
positively affect infant mortality rate of the Philippines.  However, health expenditure is not 
sufficient enough to affect under five mortality rate. These results support the studies of 
Day and Tousignant (2005) and Anyanwu and Erhijakpor (2007) that though greater 
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expenditure for health outcomes is being implemented by the government, little empirical 
evidence exists on the beneficial impact of such expenditure to child mortality rates. 
 
The results also revealed that GDP per capita affects the under-five mortality rate but is not 
sufficient enough to affect infant mortality rate in the Philippines. This implies that an 
increase in the past year’s values of GDP per capita would lead to a reduction of under- five 
mortality rate at the current year. On the other hand, both public health expenditure and 
GDP per capita has a positive effect to life expectancy. Thus, the previous year’s increased 
value of health expenditure and GDP per capita increases the level of life expectancy at 
present. 
 
Results on Granger causality test revealed that GDP per capita does not forecast the future 
values of health expenditure, and vice versa. Results also suggest that health expenditure 
can predict future levels of infant mortality rate and life expectancy, but not vice versa. 
Furthermore, it suggests that health outcomes can be predicted by GDP per capita and vice 
versa. 
 
From these results, the study makes the following conclusions: First, even joint efforts were 
made on the improvement of GDP per capita, it is not sufficient enough to affect infant 
mortality rate possibly because GDP per capita, used to proxy income in this study, is not 
used to spend and focus to health care alone. Second, expenditures for reducing infant 
deaths have been addressed by the programs and projects implemented by the 
government, but, an increasing expenditure for health still has no effect to under five 
mortality rate. This may suggest that the level of public health expenditure is not sufficient 
enough to have significant improvements on the reduction of under-five mortality rate. 
 
 
RECOMMENDATIONS 
 
Based from the results and conclusion, the following recommendations are made: 
 
Public health expenditure has a statistically significant effect to infant mortality rate and 
life expectancy. From the ever increasing public health expenditure, the government must 
improve policies concerning the three health outcomes and the expenditures should be 
rightfully evaluated. Improvements in health expenditure will be a big assistance in order 
to reach the 4th goal of the Millennium Development Goal on reducing child mortality. 
 
It is proven in this study that GDP per capita brings an improvement to under five mortality 
rate and life expectancy but not to infant mortality rate. All efforts should be exerted to 
sustain economic growth in the country and these efforts will then lead to a further 
improvement of health outcomes. 
 
There is also a need to improve and update the database of the Philippines in order to have 
a more detailed and updated analysis on the relationship of these variables.  
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